• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Model Number BLIS-X1
Medical Device Problem Code Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Endophthalmitis (1835); Hypopyon (1913)
Date of Event 05/06/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Although requested, the device was not returned for evaluation.As a lot number for the device was not provided, the associated device history record was not reviewed.The trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.Based on the available information, the root cause of this event could not be conclusively determined.
 
Event or Problem Description
It was reported that 2 days after implantation of an intraocular lens (iol) in the left eye, the patient presented with hypopyon and vitritis.Based on the findings, the surgeon concluded the cause as endophthalmitis.In the implanting surgeon's opinion, the most likely cause of the event could not be determined.Medication administered during original surgery: intracameral moxifloxacin.The following medications were prescribed for use at home post-operatively: prednisolone 1%: 1 gtt qid x 2 weeks, then tid x 2 weeks (total duration: 1 month) ofloxacin 0.3%: 1 gtt qid x 7 days ketorolac 0.5%: 1 gtt qid x 2 weeks, then tid x 2 weeks.(total duration: 1 month).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE
Common Device Name
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman street
rochester NY 14609
Manufacturer (Section G)
MEDICEL AG
dornierstrasse 11
altenrhein CH ¿ 9423
SZ   CH ¿ 9423
Manufacturer Contact
shayan habibi
21 north park place blvd.
clearwater, FL 33759
7277246600
MDR Report Key25551649
Report Number0001313525-2026-00080
Device Sequence Number14849057
Product Code MSS
UDI-Device Identifier00757770520183
UDI-Public(01)00757770520183
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
K131958
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 06/18/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberBLIS-X1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/20/2026
Initial Report FDA Received Date06/18/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ENVISTA IOL, AMVISC PLUS, BLIS-R1, ALCON BSS
Outcome Attributed to Adverse Event Required Intervention;
Patient Age52 YR
Patient SexMale
-
-